TIME IS TISSUE, YET EFFECTIVE WOUND MANAGEMENT CAN BE A REAL CHALLENGE
Obtain actionable data at every visit to assess, track and document medical necessity, evaluate the therapeutic efficacy, and record outcomes.
Chronic wounds are difficult to treat, cost healthcare systems billions of dollars each year, and greatly affect patient quality of life. In severe cases, these types of wounds can lead to limb amputation. Current diagnostic tools to assess tissue health are either costly or difficult to employ (or both), and visual assessment alone is not adequate to see the whole picture.
SnapshotNIR is an easy-to-use, cost-effective, and repeatable tool to assess and track the tissue oxygen level in a patient, whether at a wound site or in an area of vascular concern. SnapshotNIR provides medical professionals value-based insight into the ongoing healing process when assessing and treating chronic wounds.
Blood perfusion is necessary to supply oxygen to tissues and is generally measured in the macrovascular network. This perfusion, although critical, does not necessarily mean that the oxygen is being successfully offloaded in the tissues at the microvascular or capillary network level, as perfusion can exist with very limited oxygen bound to hemoglobin.
WOUND MONITORING AND ASSESSMENT
Using near-infrared spectroscopy imaging with SnapshotNIR provides a clinician with near-instantaneous insight into “what lies beneath,” through the capture and display of tissue oxygenation in and around a wound. This actionable data can improve in situ decision-making to impact patient outcomes and provides the ability to easily track and document medical necessity, therapeutic efficacy and results.
With the click of a button on the hand-held device, you can capture images to assess tissue response to this advnaced therapy. These images help to confirm qualification for continued hyperbaric oxygen treatment.
Due to its ease of use in assessing tissue response to therapy, more patients can be screened and qualified for HBOT treatment with expedited referrals.
When patient’s see progress occurring below the surface – something they cannot see with their eyes – they are much more likely to comply with the full course of treatment.
The data captured helps the clinician evaluate and document therapeutic efficacy. This supports the decision on how many dives are effective for each patient, helping to keep your chambers full with patients deriving treatment benefit. The images also help to indicate when it is time to stop.
The images captured and compared with each dive cycle provides medical necessity documentation for continued efficacy, which may help to expedite approval from 3rd party payors for the continuation of treatment.
HYPERBARIC OXYGEN THERAPY
SnapshotNIR‘s near-infrared spectroscopy imaging not only helps to qualify a patient for hyperbaric oxygen treatment and to clearly document ongoing therapeutic efficacy, it aids in keeping patients engaged and committed to the treatment program by effectively demonstrating improvements to tissue health following each set of dives.
As a non-invasive tissue assessment device, Snapshot can triage patients earlier in the care process and expedite referral to integrated specialties, including vascular, enhancing interdisciplinary communication.
Using the oxygenation data provided, Snapshot helps focus on wound bed preparation helping to guide how much tissue to debride. Capturing images pre- and post intervention gives timely feedback which can positively impact the clinician’s next move.
If a treatment path is not providing the expected benefits, Snapshot can support the decision to implement a change more quickly to expedite wound healing.
Snapshot provides the ability to capture linear and area measurements directly on the images and store these in the patient record for easy numerical and visual comparison over time, speeding-up clinical workflow.
Healing can be tracked and documented with Snapshot, with image reports easily added to the patient record. These documented reports can be used support medical necessity and proof of therapeutic efficacy for 3rd party reimbursement.
CELLULAR AND/OR TISSUE PRODUCTS (CTPs)
Using near-infrared spectroscopy imaging with SnapshotNIR can be very helpful in delivering better outcomes with respect to CTPs. SnapshotNIR can assist in identifying if a CTP will successfully integrate into the wound bed and promote angiogenesis by identifying a well-prepared and oxygenated wound bed.
The easily captured images help to quickly assess the vascular status of the wound bed and peri-wound. Is there adequate perfusion and oxygenation to support the procedure?
The tissue oxygenation images help “see”, or validate when a wound bed is optimally prepared with adequate oxygenation in all regions of the peri-wound and the wound margin, which is more likely to lead to adherence, integration and tissue granulation for expedited healing rather than to failure.
Using the built-in measurement tools, you can document the wound size area and linear dimensions to help select the best size of tissue application, reducing potential product wastage.
Healing can be tracked and documented, with the image reports easily added to the patient record. These documented reports can be used to support medical necessity and proof of therapeutic efficacy for 3rd party reimbursement.
Access to non-invasive vascular assessments (NIVA) are limited and the type of NIVA is specialty specific, with no simple solution existing across specialties. This creates confusion in identifying ischemic events in a health system or throughout the care continuum. Many healthcare professionals rely on clinical judgement alone in their assessment of the tissue due to complexities, costs, and inconsistencies in obtaining NIVAs at all care points.
Increasing access to non-invasive vascular assessments triages patients earlier in the care stream and accelerates intervention at the appropriate point-of-care. Assessing the tissue post-intervention in the OR can help optimize the therapy and provide a method for regular monitoring.
A 66-year-old female patient with type II diabetes, hypertension, morbid obesity, and no known history of peripheral arterial insufficiency was being seen by neurology for leg pain. Severe arterial disease was documented by utilizing SnapshotNIR images on the wound care study's initial evaluation, leading to subsequent vascular evaluations and treatment.
SnapshotNIR is a non-invasive vascular assessment that uses near-infrared light to identify the ratio of oxygenated to deoxygenated hemoglobin. This provides the medical professional with a low-cost measure of soft tissue oxygenation in a simple and consistent manner, at any care point.
Evaluating tissue health is critical to eliminating easily preventable flap failures. Post-op monitoring is done to ensure flap survival but can be very costly. Due to the expensive costs of ICG fluorescence angiography, many surgeons rely on clinical judgment alone. Yet poorly oxygenated skin flaps are often not clinically apparent until hours after surgery, at which point, they are more difficult to salvage and may have additional complications.
SnapshotNIR, without the need for dyes, injections, or even patient contact, helps to detect tissue viability issues in skin flaps earlier, allowing clinicians to intervene more quickly, helping to reduce complications and manage healthcare costs. With the portable footprint and low-price-point, SnapshotNIR brings tissue assessment to “every” surgeon, providing non-invasive monitoring that can be done anywhere – in the PACU or ICU, on the floor, or in the home.
